• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Role of prostaglandin receptor signaling inenhancement of lymphangiogenesis and application to metastasis treatment

Research Project

  • PDF
Project/Area Number 23790302
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field General pharmacology
Research InstitutionKitasato University

Principal Investigator

HOSONO Kanako  北里大学, 医学部, 助教 (80532556)

Project Period (FY) 2011 – 2012
Keywordsリンパ管新生 / プロスタグランジン / 慢性炎症 / ノックアウトマウス / がん / リンパ節転移
Research Abstract

Lymphangiogesis, the formation of lymphatic vessels from pre-existing lymphatic vessels, plays an important role in homeostasis, metabolism and immunity. Recent evidenceindicates that lymphangiogenesis, similar to angiogenesis, also occurs during certain inflammatory and autoimmune conditions. I examined the effects of COX-2 and endogenous PGE2on lymphangiogenesis during chronic inflammation. Lymphangiogenesis was upregulated during the development of granulation tissues, which were formed around Matrigel plugs in response to inductions of COX-2 and mPGES-1. Administration of a COX-2 inhibitor (celecoxib) significantly reduced lymphatic vessel formation in granulationtissues, whereas topical PGE2administration enhanced lymphangiogenesis.Lymphangiogenesis was suppressed in the granulation tissues of mice lacking either EP3 or EP4, suggesting that these molecules are receptors for PGE2. An EP3-selective agonist (ONO-AE-248) increased the expression of VEGF-C and VEGF-D in cultured macrophages, while an EP4-selective agonist (ONO-AE1-329) increased VEGF-C expression in cultured macrophages and increased VEGF-D expression in cultured fibroblasts. Thus, our findings demonstrate that EP3 and EP4 signaling contributes to inflammation-associated lymphangiogenesis by upregulating VEGF-C and VEGF-D in fibroblasts and macrophages. In addition, prostaglandin receptor signaling appears critical for tumorassociated lymphangiogenesis and tumor growth. From now on, I would like to continue an examinationbased on these findings about the metastasis in lymph node.

  • Research Products

    (7 results)

All 2013 2012 2011 Other

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (4 results) Remarks (1 results)

  • [Journal Article] Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema2011

    • Author(s)
      Kashiwagi S, Hosono K, Suzuki T, Takeda A, Uchinuma E, Majima M
    • Journal Title

      Lab Invest

      Volume: 91(9) Pages: 1314-25

    • DOI

      DOI:10.1038/labinvest.2011.84

    • Peer Reviewed
  • [Journal Article] Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesisduring fibroblast growth factor-2-induced granulation formation2011

    • Author(s)
      Hosono K, Suzuki T, Tamaki H, Sakagami H,Hayashi I, Narumiya S, Alitalo K, Majima M
    • Journal Title

      Arterioscler Thromb Vasc Biol

      Volume: 31(5) Pages: 1049-58

    • DOI

      DOI:10.1161/ATVBAHA.110.222356

    • Peer Reviewed
  • [Presentation] Role of COX-2 in enhancement of lymphangiogenesis in diaphragm after the peritoneal application of endotoxin2013

    • Author(s)
      松田弘美、細野加奈子、蔵重千絵、馬嶋正隆
    • Organizer
      第86回日本薬理学会年会
    • Place of Presentation
      福岡
    • Year and Date
      20130321-23
  • [Presentation] Roles of prostaglandin E2-EP3/EP4 receptor signalings in enhancement of lymphangiogenesis during inflammation2012

    • Author(s)
      細野加奈子、馬嶋正隆
    • Organizer
      第36回リンパ学会
    • Place of Presentation
      東京
    • Year and Date
      20120630-0701
  • [Presentation] Role of cyclooxygenase-2 in enhancement of lymphangiogenesis during wound healing2012

    • Author(s)
      細野加奈子、鈴木立紀、成宮周、馬嶋正隆
    • Organizer
      第86回日本薬理学会年会
    • Place of Presentation
      京都
    • Year and Date
      20120314-16
  • [Presentation] 創傷治癒時のリンパ管新生におけるプロスタグランジン E2 およびその受容体シグナリングの役割2012

    • Author(s)
      細野加奈子、鈴木立紀、成宮周、馬嶋正隆
    • Organizer
      第126回日本薬理学会関東部会
    • Place of Presentation
      東京
    • Year and Date
      2012-07-14
  • [Remarks] 北里大学医学部薬理学 大学院・医療系研究科分子薬理学

    • URL

      http://www.med.kitasato-u.ac.jp/pharm/

URL: 

Published: 2014-09-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi